Avalo Therapeutics (AVTX) announced the appointment of Rita Jain, M.D. to its Board of Directors. Jain most recently served as Executive Vice President and Chief Medical Officer at ChemoCentryx
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX: